2nd Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for ABBVIE
Client
Income
$60,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER | — |
Trade (domestic/foreign) TRD
Issues related to trade treaty legislation; USMCA
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH ANNE MAIER | — |
Taxation/Internal Revenue Code TAX
Issues related to excise tax
| Lobbyist | Covered position, as disclosed |
|---|---|
| RUSSELL W. SULLIVAN | — |
Health Issues HCR
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| DAVID PHILLIP COHEN New | Prof. Staff-House Comm on Banking & Fin Svcs |
| NADEAM ELSHAMI | — |
| ELIZABETH ANNE MAIER | — |
| ALFRED MOTTUR | — |
| JEROME MURRAY | — |
| ZACHARY PFISTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.